Genotype- and Phenotype-Guided Management of Congenital Long QT Syndrome
Key result
Genotype- and phenotype-guided approaches to the clinical management of congenital long QT syndrome have evolved from an improved understanding of the molecular underpinnings of the disease.
Population
Patients with congenital long QT syndrome (LQTS)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Genotype-phenotype guidance may refine LQTS care; leaves open prospective validation before practice change.
Key Points
- To review the electrophysiological mechanisms, genotype-phenotype relationships, and personalized management strategies for congenital long QT syndrome.
- Synthesized two decades of clinical and molecular evidence concerning congenital long QT syndrome pathogenesis.
- Evaluated the functional impact of mutations across 15 LQTS-susceptibility genes encoding cardiac ion channel α- and β-subunits.
- Mutations in 15 distinct LQTS-susceptibility genes alter cardiac action potentials and directly disrupt myocardial repolarization.
- Established genotype-phenotype correlations enable precision risk stratification, targeted pharmacological therapies, and customized clinical interventions.
Structured PICO
P
Population
Patients with congenital long QT syndrome (LQTS)
I
Intervention
Genotype- and phenotype-guided approaches to clinical management
Understanding the molecular basis of congenital long QT syndrome enables genotype- and phenotype-guided approaches to diagnosis, risk stratification, and treatment.
Cite This Study
Giudicessi et al. (2013) conducted a review in Congenital long QT syndrome (LQTS). Genotype- and phenotype-guided management was evaluated. Genotype- and phenotype-guided approaches to the clinical management of congenital long QT syndrome have evolved from an improved understanding of the molecular underpinnings of the disease.